insitro is a biotechnology company focused on discovering and designing therapeutics for neuroscience and metabolic diseases. It operates at the intersection of life sciences and data science, applying causal AI and machine learning to multi-modal human data. The company's stated approach is to use these methods to understand how diseases begin, progress, and can be resolved.
The company's key technical platform is the Virtual Human™, a genetically anchored causal AI engine built on what it describes as the world's largest integrated multi-modal corpus of human and cellular data. This platform is complemented by the TherML™ AI platform, which is deployed to design medicines by identifying causal genetic drivers. These systems are central to insitro's drug discovery pipeline.
insitro operates within the pharmaceuticals and biotechnology verticals, specifically in drug discovery. Its work requires close integration of diverse expertise, and the company notes a collaborative culture where life scientists, data scientists, engineers, and drug hunters work together to generate scientific breakthroughs.
